Filter Results :

Your search for Biosimilars returned 63 reports

Sort by


2015 Deep Research Report on Global Biologics and Biosimilars Industry

03 Mar 2015  |  Published by:  QYResearch
Summary  2015 Deep Research Report on Global Biologics and Biosimilars Industry is a professional and depth research report on Global Biologics and Biosimilars industry.  For overview analysis, the report introduces Biologics and Biosimilars basic information including definition, ...

$ 2,600.00

Read More

Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin

15 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin provides a competitor evaluation in the field of recombinant antibodies targeting Her2 for treatment of Her2 positive breast and gastric cancer as of February 2015. Purchase of the downl...

$ 326.62

Read More

Competitor Analysis: VEGF & VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis

08 Feb 2015  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis provides a competitor evaluation in the field of recombinant antibodies targeting vascular endothelial growth factor (VEGF) or its receptors (VEGF-R) used to treat ...

$ 381.06

Read More

2015 Market Research Report on Global Biologics and Biosimilars Industry

02 Feb 2015  |  Published by:  QYResearch
2015 Market Research Report on Global Biologics and Biosimilars Industry is a professional and depth research report on Global Biologics and Biosimilars industryFor overview analysis, the report introduces Biologics and Biosimilars basic information including definition, classification, application,...

$ 2,600.00

Read More

Japan Pharma Outlook 2015: 2015 - Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

27 Jan 2015  |  Published by:  MP Advisors
The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating their domestic (and thus overseas) strategies to adopt with new regulations. For the inn...

$ 2,000.00

Read More

Biosimilars: European Payer Perspectives

06 Jan 2015  |  Published by:  FirstWord
Cost is king when it comes to European biosimilars. One issue unites European healthcare payers: the need to provide biosimilars at the most affordable price in cash constrained health services. Biosimilars: European Payer Perspect...

$ 1,950.00

Read More

Biosimilars: Global Markets

01 Jan 2015  |  Published by:  BCC Research
The global biosimilars market was valued at $1.8 billion in 2013 and nearly $2.0 billion in 2014. The market is expected to reach nearly $4.0 billion by 2019, with a compound annual growth rate (CAGR) of 15% from 2014 through 2019. This report provides:-An overview of the global market for bi...

$ 6,650.00

Read More

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

31 Dec 2014  |  Published by:  GlobalData
SummaryRheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects over seven million individuals in the 10MM covered in this report (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India) and the prevalence is expe...

$ 3,495.00

Read More

Global Oncology Biosimilars Market 2014-2018

19 Nov 2014  |  Published by:  Technavio
Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to ...

$ 2,500.00

Read More

Europe Biosimilars Market & Pipeline Insight

08 Oct 2014  |  Published by:  KuicK Research
Biosimilars have emerged as one of the most promising segment of the European pharmaceutical industry in recent years. The biosimilars segment has been experiencing a steady growth driven by patent expiration of blockbuster drugs, amenable regulatory framework, economic incentives along with f...

$ 2,400.00

Read More

Biosimilars in Emerging Markets: Opportunities, Challenges and Critical Success Factors

02 Sep 2014  |  Published by:  FirstWord
The biosimilars industry is increasingly focusing its attention on emerging markets, a move that offers both enormous potential and challenges. FirstView’s Biosimilars in Emerging Markets: Opportunities, Challenges and Critical Success Factors report offers timely insight into the right strate...

$ 1,950.00

Read More

Global Biosimilars Market Regulations & Pipeline Insight

02 Sep 2014  |  Published by:  KuicK Research
The evolution of biosimilars has currently reached different stages across the world. Owing to variable clarity in the guidelines and diverse regulatory pathways, various definitions of biosimilars (or the broader group of follow-on biologics) have emerged across countries. Till now the Europe...

$ 2,400.00

Read More

Pharmacutical Market INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines

01 Aug 2014  |  Published by:  Kelly Scientific Publications
PHARMACEUTICAL MARKET INDIA 2014-2020, Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services (CRAMS), Biosimilars, Generics & Vaccines” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry...

$ 3,048.47

Read More

Biosimilars - Biosimilars on the cusp of a new era

31 Jul 2014  |  Published by:  GBI Research
SummaryThe biosimilars market is undergoing rapid change with developments such as the recent approvals of infliximab and trastuzumab heralding a new era. In order to keep up with the pace of change in the marketplace, regulatory agencies have been developing updated guidance around ...

$ 2,995.00

Read More

PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market

30 Jun 2014  |  Published by:  GlobalData
Summary"PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market", provides strategic analysis of the global biosimilars industry. It discusses key market trends, regulatory requirements in various markets, recent deals activity and trends, as well as describes the ...

$ 2,995.00

Read More
Total 63 records.